47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
68.31.Z - Real estate brokerage
68.32.Z - Other real estate activities on behalf of third parties
86.10.Z - Hospital activities
86.90.A - Healthcare
86.90.C - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -22,8 | -20,6 | 41,6 | 302,3 |
EBITDA | -2,6 | -17,9 | 158,2 | 982,3 |
Short time liabilities | 37,1 | 272,5 | 91,5 | -66,4 |
Equity capital | -21 | -41,6 | 0 | 100 |
Operating profit (EBIT) | -22,8 | -20,5 | 41,6 | 303,3 |
Assets | 16,1 | 566 | 564,2 | -0,3 |
Net profit (loss) | -22,8 | -20,6 | 41,6 | 302,3 |
Cash | 6,8 | 109,8 | 119,5 | 8,9 |
Net income from sale | 59,1 | 107 | 640,5 | 498,6 |
Liabilities and provisions for liabilities | 37,1 | 607,5 | 564,2 | -7,1 |
Working assets | 14,9 | 121,8 | 256,3 | 110,5 |
Depreciation | 20,3 | 2,5 | 116,6 | 4499,1 |
% | % | % | p.p. | |
Profitability of capital | 108,7 | 49,5 | 352 180,2 | 352 130,7 |
Equity capital to total assets | -130,6 | -7,3 | 0 | 7,3 |
Gross profit margin | -38,7 | -19,2 | 6,5 | 25,7 |
EBITDA Margin | -4,4 | -16,8 | 24,7 | 41,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 229 | 930 | 52 | -878 |
Current financial liquidity indicator | 0.401358425617218 | 0.4467102289199829 | 2.8005425930023193 | 2,4 |
Net dept to EBITDA | -6.9330315589904785 | -12.563464164733887 | 2.2322278022766113 | 14,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane